Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $1.54 Million - $1.82 Million
-16,100 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $1.01 Million - $1.7 Million
16,100 New
16,100 $6.53 Million
Q4 2019

Feb 14, 2020

SELL
$36.62 - $57.29 $915,499 - $1.43 Million
-25,000 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$35.53 - $43.8 $888,250 - $1.1 Million
25,000 New
25,000 $3.73 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Summit Partners Public Asset Management, LLC Portfolio

Follow Summit Partners Public Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.